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Introduction
Premenstrual syndrome (PMS) is characterized by 
affective and somatic symptoms appearing in the days 
preceding menses and interfering with women’s daily 
life [1]. The American College of Obstetricians and Gy-
necologists (ACOG) criteria suggest the following PMS 
diagnosis: A clinical condition characterized by the cyclic 
presence of emotional and physical symptoms unrelat-
ed to any organic disease that appear during the luteal 
phase in each of the three prior menstrual cycles and 
spontaneously disappear within 4 days of the menstru-
al cycle onset, and do not relapse until at least cycle day 
13 [2]. Women who experience PMS tend to report low 
health-related quality of life, frequent visits to health 
providers, decreased occupational productivity, and 
greater psychiatric comorbidities [3-5]. PMS prevalence 
varies worldwide, ranging from 12% (95% CI: 11-13) in 
France to 98% (95% CI: 97-100) in Iran. A meta-analy-
sis showed an increasing trend in PMS prevalence. The 
pooled of PMS rate estimated from 12 countries located 
in Asia, Africa, South America and Europe’s continents 
was found to be 48% (95% CI: 33-63) [6].
More than 20% of women have affective and so-
matic premenstrual symptoms that are clinically rele-
vant [4]. The most common symptoms reported from 
developed countries such as Japan, Spain and France 
include lack of energy and anxiety [7], breast tender-
ness, headaches, muscular pain, and irritability [8], and 
anxiety [9] respectively. In developing countries such 
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Objectives: This study aimed to estimate the prevalence 
and examine the characteristics of premenstrual syndrome 
(PMS) among female university students. It also aimed to 
determine the factors associated with the affective and so-
matic domains of PMS.
Methods: This cross sectional study was conducted among 
2115 Lebanese female university students, who completed 
questionnaires on PMS symptoms and other factors. PMS 
was defined according to the “American College of Obste-
tricians and Gynecologists” criteria. Bivariate and multivari-
able associations between PMS, PMS affective and somatic 
domains respectively and other covariates were conducted 
using logistic regression.
Results: Almost 63% of participants reported having PMS 
with 42.5% having severe PMS. The most common affec-
tive and somatic symptoms were “angry outbursts” and “ab-
dominal bloating” respectively. Obesity, having unemployed 
fathers, caffeine consumption (coffee/tea), and pain medi-
cation use, and sleeping pill use were significantly associat-
ed with PMS. Among these factors, caffeine consumption, 
and medication use for pain were associated with PMS af-
fective domain while BMI, caffeine consumption, and med-
ication use for pain were related to PMS somatic domain.
Conclusion: The proportion of Lebanese females with 
PMS and affective and somatic symptoms are notably high. 
These findings highlight the importance of weight manage-
ment to minimize PMS symptoms.
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as Turkey, Lebanon and Nigeria, the most common re-
ported symptoms were abdominal bloating and irritabil-
ity [10], and breast tenderness [11,12]. The etiology of 
PMS has not yet been clearly elucidated [1,13]. Genetic, 
environmental, and psychological factors could impact 
hormonal fluctuations and thus lead to PMS symptoms 
[1,3,6,13]. Cyclical ovarian activity and the effect of es-
tradiol and progesterone on the neurotransmitters like 
serotonin and gamma-amino butyric acid (GABA) ap-
pear to play key roles [3,6,13]. Absence of PMS before 
puberty, during pregnancy and after the menopause 
supports the theory that cyclical ovarian activity is im-
portant in PMS development.
Research describing PMS in Lebanon is limited to two 
brief communications aimed to assess menstrual cycle 
abnormalities and PMS prevalence respectively [12,14]. 
Both studies were conducted in a single university/med-
ical center and among a small number of participants. 
The premenstrual syndrome (PMS) is particularly com-
mon in the younger age groups and therefore presents 
a significant public health problem among young girls. 
Therefore, assessing PMS, the factors associated with 
it as well as its symptoms in Lebanese females is need-
ed. This study will estimate the proportion, severity and 
factors of PMS among Lebanese female university stu-
dents. Moreover, it will explore the affective and somat-
ic PMS domains as well as their respective associated 
factors.
Methods
Study design and population
This cross-sectional study was conducted during the 
Spring semester of 2015-2016 among female univer-
sity students in Lebanon. The study was conducted at 
five large universities located within the Greater Beirut 
area, which includes more than 50% of university stu-
dents in Lebanon, with a convenience sampling method 
being applied to enroll participants. Participants were 
recruited from four private universities and one public 
university, namely the Lebanese University, and from 
the following faculties: Sciences, medicine, humanities, 
business, and engineering. Participants were recruited 
throughout the semester up until 2 weeks prior to the 
final exam period. Flyers inviting participants to partake 
in this study were distributed in each of the campuses of 
the participating universities. Students who were inter-
ested in participating in the study were invited to meet 
in an auditorium where they were informed about the 
purpose of the study and were invited to participate in 
the survey. Participation in the study was voluntary, and 
did not involve financial or any other compensation. 
After being screened for inclusion/exclusion criteria, 
students were then asked to complete an anonymous 
questionnaire that was administered by a trained re-
search assistant. The questionnaire required less than 
15 minutes to be completed. In order to be included 
in the study, participants had to be female, Lebanese, 
and currently registered as full-time undergraduate stu-
dents in the academic year 2015-2016 at the Lebanese 
and private universities. Ethics approval was obtained 
from the institutional review board at the Lebanese Uni-
versity. All participants signed a written informed con-
sent form.
Sample size calculation
According to a previous study on PMS conducted in 
Lebanon, sample size was determined for a PMS preva-
lence of 7.1% [12]. Using the following formula for sam-
ple size calculation (N) = (Za² × p × q)/d² and with an α 
error of 5% and a margin of ± 1.1%, 2094 participants 
were needed for the study.
Eligibility criteria
Participants were excluded if they had any medical 
condition interfering with the menstrual cycle such as 
endometriosis, pelvic inflammatory disease, uterine 
cancer and uterine fibroids. Students were asked about 
any of these medical conditions before completing the 
questionnaires. Overall, 2500 female students were 
found to be eligible and voluntarily participated. Among 
them, 50 were excluded as having the above mentioned 
medical conditions that interfere with the menstrual cy-
cle. Moreover, 335 had incomplete information data for 
the following sociodemographic characteristics: Family 
profile, father or mother education, and father or moth-
er income per month. After these exclusions, 2115 par-
ticipants were included in the analysis.
Data collection and measures
A self-administered, structured, anonymous ques-
tionnaire was used and administered in English. The 
questionnaire consisted of four sections. The first sec-
tion included questions on sociodemographic charac-
teristics such as age, weight, height, age of menarche 
(>= 12 versus < 12-years-old), family profile (one or 
both parents dead versus parents alive), parents’ occu-
pations (employed versus not), educations (university 
level versus high school or below) and monthly incomes 
(>= US$ 2000 versus < US$ 2000). The second part con-
sisted of items describing lifestyle characteristics such 
as living conditions (in university dormitory versus with 
a family or others), physical activity (>= 3 times versus < 
3 times per week), smoking status (current smokers ver-
sus non-smokers and ex-smokers), caffeine and energy 
drink consumption (yes, no; if yes quantity per week). 
The third part included questions related to medication 
use in the past month such as calcium, vitamin D and 
contraceptive pills, as well as medications used for pain, 
nausea, vomiting, depression, weight gain, and sleeping 
pills. The fourth section consisted of 33 questions relat-
ed to PMS affective and somatic symptoms as well as 
symptoms that accompany PMS, which are not includ-
ed in PMS’ definition, that were experienced by female 
university students five days prior to menses in each of 
the three prior menstrual cycles. These symptoms were 
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suicide during the five days preceding menses in each 
of the three prior menstrual cycles. PMS somatic do-
main was defined as having at least one of the following 
symptoms: Breast tenderness, swelling of extremities, 
abdominal bloating, fluid retention or headache during 
the five days preceding menses in each of the three pri-
or menstrual cycles.
Statistical analyses
Descriptive statistics were performed to determine 
percentages of the participants’ characteristics, PMS, 
severe PMS, and affective and somatic symptoms that 
accompany PMS. The associations between PMS versus 
non-PMS groups and PMS symptoms were assessed by 
the Chi square test. Then, individual relationships be-
tween 1) PMS and the sociodemographic, lifestyle fac-
tors, and medication use, and 2) Between PMS, PMS 
affective domain, and PMS somatic domain and symp-
toms that accompany PMS were evaluated. Multivari-
able regression analyses were then conducted in order 
to evaluate 1) The association between the outcome, 
PMS, and participants’ characteristics while adjusting 
for potential confounders, 2) PMS/PMS affective do-
main/PMS somatic domain and symptoms that accom-
pany PMS, which were not included in the PMS defini-
tion. All variables having a P-value < 0.05 in the bivariate 
analysis were included in the multivariable regression 
analysis. An alpha of 0.05 was used to determine sta-
tistical significance. All analyses were performed using 
SPSS version 22.0 (IBM, Inc, Chicago, IL).
Results
Characteristics of the females who participated in 
this study (n = 2115) are shown in Table 1. Around 64% 
had normal BMI, 24% were current smokers, and 61% 
abstracted based on those listed within the Diagnostic 
and Statistical Manual of Mental Disorders (DSM-V) 
[15]. The participants rated the presence and severity 
of their symptoms based on a 4-point Likert scale from 
none (= 0) to mild (= 1) to moderate (= 2) to severe (= 
3). Mild symptoms were defined as not limiting the dai-
ly activity, while moderate symptoms were considered 
if marked limitations with regard to daily activity were 
noted. Severe symptoms were considered if partici-
pants were unable to achieve the daily activities with-
out discomfort [16]. Mild symptoms were merged with 
the category of no symptom in every variable which in-
dicates the absence of the symptom and moderate and 
severe symptoms were merged together to indicate the 
presence of the symptom.
PMS definition
The prevalence of PMS, the main outcome variable 
in this study, was detected according to the diagnostic 
criteria proposed by the American College of Obstetri-
cians and Gynecologists (ACOG) [2]. The presence of 
PMS was based on ACOG criteria as defined by females 
reporting at least 1 affective and 1 somatic symptom 
during the 5 days before menses over 3 consecutive 
menstrual cycles. The symptoms must be relieved with-
in 4 days of the onset of menses, without any recur-
rence until at least cycle day 13 and be present in the 
absence of any pharmacologic therapy or alcohol use. 
Participants were asked to record the start date and 
end date of the symptoms in relation to the onset of 
menses. Participants who reported moderate or severe 
symptoms were considered as having PMS. PMS affec-
tive domain was defined as having at least one of the 
following symptoms: Depression, anxiety, angry out-
bursts, irritability, confusion or the thought to commit 
Table 1: Frequencies of sample characteristics for all participants and by PMS status.
All participants N = 
2115 N (%)
Non-PMS, N = 
794 N (%)
PMS, N = 1321 
N (%)
Age, years [17-21]
[21-29]
1217 (57.5)
898 (42.5)
476 (59.9)
318 (40.1)
741 (56.1)
580 (43.9)
Body mass index (BMI) < 18.5 kg/m²
18.5 - 25 kg/m²
25 - 30 kg/m²
>= 30 kg/m²
261 (12.3)
1362 (64.4)
352 (16.6)
140 (6.60)
118 (14.9)
531 (66.9)
109 (13.7)
36 (4.50)
143 (10.8)
831 (62.9)
243 (18.4)
104 (7.90)
Smoking status Current smokers, % 504 (23.8) 181 (22.8) 323 (24.5)
Age at menarche, years < 12
>= 12 
683 (32.3)
1432 (67.7)
243 (30.6)
551 (69.4)
440 (33.3)
881 (66.7)
Family profile (parents) Alive
Dead (1 or both)
2012 (95.1)
103 (4.90)
769 (96.9)
25 (3.10)
1243 (94.1)
78 (5.90)
Mother education High school or below
University 
1332 (63.0)
783 (37.0)
492 (62.0)
302 (38.0)
840 (63.6)
481 (36.4)
Mother occupation Employed, Yes % 670 (31.7) 248 (31.2) 422 (31.9)
Mother income/month US$ < 2000
US$ >= 2000
517 (77.2)
153 (22.8)
188 (75.8)
60 (24.2)
329 (78.0)
93 (22.0)
Father education High school or below
University
1423 (67.3)
692 (32.7)
527 (66.4)
267 (33.6)
896 (67.8)
425 (32.2)
Father occupation Employed, Yes % 1977 (93.5) 757 (95.3) 1220 (92.4)
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group, PMS group included more obese participants, 
more females whose parents were dead (one or both), 
and more females with unemployed fathers. Moreover, 
were attending the Lebanese university. Almost 63% 
of participants reported PMS. Among them, 42.5% (n = 
562) reported severe PMS. Compared to the non-PMS 
Father income/month US$ < 2000
US$ >= 2000
1044 (52.8)
933 (47.2)
415 (54.8)
342 (45.2)
629 (51.6)
591 (48.4)
Living conditions Dorms
With parents
Others
466 (22.0)
1560 (73.8)
89 (4.20)
158 (19.9)
606 (76.3)
30 (3.80)
308 (23.3)
954 (72.2)
59 (4.50)
University Public
Private 
1291 (61.0)
824 (39.0)
504 (63.5)
290 (36.5)
787 (59.6)
534 (40.4)
Major Sciences & Medical 
Humanities & Business
Engineering
756 (35.7)
938 (44.3)
421 (19.9)
292 (36.8)
327 (41.2)
175 (22.0)
464 (35.1)
611 (46.3)
246 (18.6)
Exercise/week < 3 times
>= 3 times
1660 (78.5)
455 (21.5)
614 (77.3)
180 (22.7)
1046 (79.2)
275 (20.8)
Caffeine consumption Yes %
1 cup/day
2-3 cups/day
>= 3 cups/day
1475 (69.7)
691 (46.8)
683 (46.3)
101 (6.80)
496 (62.5)
272 (54.8)
210 (42.3)
14 (2.80)
979 (74.1)
419 (42.8)
473 (48.3)
87 (8.90)
Energy drink consumption Yes %
1 drink/day
2-3 drinks/day
>= 3 drinks/day
401 (19.0)
285 (71.1)
54 (13.5)
62 (15.5)
140 (17.6)
114 (81.4)
16 (11.4)
10 (7.10)
261 (19.8)
171 (65.5)
38 (14.6)
52 (19.9)
Calcium supplements Yes % 1786 (84.4) 115 (14.5) 214 (16.2)
Vitamin D supplements Yes % 1680 (79.4) 162 (20.4) 273 (20.7)
Contraceptive pills Yes % 1794 (84.8) 107 (13.5) 214 (16.2)
Medication used for Pain, Yes %
Nausea, Yes %
Vomiting, Yes %
Depression, Yes %
Weight gain, Yes %
Sleeping pills, Yes %
1095 (51.8)
358 (16.9)
275 (13.0)
-
-
103 (4.90)
355 (44.7)
93 (11.7)
70 (8.80)
-
-
17 (2.10)
740 (56.0)
265 (20.1)
205 (15.5)
-
-
86 (6.50)
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Figure 1: Differences in PMS affective and somatic symptoms (expressed as %) between non-PMS and PMS groups.
PMS affective symptoms: Depression, anxiety, anger, irritability, confusion, and the thought to commit suicide respectively.
PMS somatic symptoms: Breast tenderness, swelling of extremities, abdominal bloating, water retention and headache re-
spectively.
P-value for each symptom compared between non-PMS and PMS groups is < 0.001.
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respectively], having unemployed fathers [0.65 (0.42; 
0.99)], and 0.65 (0.42; 0.99) for an income of US$ < 2000 
and >= 2000 per month versus none respectively, caf-
feine consumption [1.39 (1.11; 1.73), 1.86 (1.48; 2.35) 
and 3.81 (2.04; 7.12) for 1 cup, 2-3 cups and >= 3 cups 
per day respectively], and medication use for pain [1.34 
(1.11; 1.62)], and for sleeping pills [2.15 (1.23; 3.76)] (Ta-
ble 2). The majority of participants reported experienc-
ing mood swings, emotional lability and craving sweets 
PMS participants consumed more caffeine, and used 
more medications for pain, nausea, vomiting and sleep-
ing pills. The most common affective symptom was an-
gry outbursts (77.4%); while the most common somatic 
symptom was abdominal bloating (70.8%), as seen in 
Figure 1.
The following factors were related to having PMS: 
Obesity [adjusted (a) OR (95% CI) = 1.56 (1.10; 2.20) and 
1.92 (1.20; 3.06) for overweight and obese participants 
Table 2: Unadjusted and adjusted associations between sociodemographic, health behavior and health related factors and PMS 
among premenopausal females in Lebanon.
Unadjusted OR 
(95% CI)
Adjusted OR (95% CI)
Age, years [21-29] vs. [17-21] 1.17 (0.98; 1.40) -
Body mass index (BMI), kg/m² < 18.5 
18.5 - 25 
25 - 30 
>= 30 
1.00
1.29 (0.99; 1.69)
1.84 (1.32; 2.57)*
2.38 (1.52; 3.74)*
1.00
1.26 (0.96; 1.66)
1.56 (1.10; 2.20)*
1.92 (1.20; 3.06)*
Smoking status Smokers vs. non-smokers and ex-smokers 1.10 (0.89; 1.35) -
Age of menarche, years >= 12 vs. < 12 0.88 (0.73; 1.07) -
Family profile Dead (1 or both) vs. alive 1.93 (1.22; 3.06)* 1.57 (0.95; 2.58)
Mother education University vs. high school or below 0.93 (0.78; 1.12) -
Mother occupation Employed vs. housewife 1.03 (0.86; 1.25) -
Mother income/month None (housewife)
US$ < 2000
1.00
1.06 (0.86; 1.31)
-
US$ >= 2000 0.94 (0.67; 1.33)
Father education University vs. high school or below 0.94 (0.78; 1.13) -
Father occupation Employed vs. unemployed 0.59 (0.40; 0.87)*
Father income/month None (unemployed)
US$ < 2000
1.00
0.56 (0.37; 0.83)*
1.00
0.62 (0.40; 0.95)*
US$ >= 2000 0.63 (0.43; 0.94)* 0.65 (0.42; 0.99)*
Living conditions Dorms
With parents
Others
1.00
0.81 (0.65; 1.003)
1.01 (0.63; 1.63)
-
University Private vs. public 1.18 (0.98; 1.41) -
Major Sciences & Medical 
Humanities & Business
Engineering
1.00
1.18 (0.96; 1.43)
0.89 (0.69; 1.13)
-
Exercise/week >= 3 times vs. < 3 times 0.90 (0.73; 1.11) -
Caffeine consumption None
1 cup/day
2-3 cups/day
>= 3 cups/day
1.00
1.34 (1.08; 1.67)*
1.96 (1.57; 2.46)*
5.42 (3.02; 9.72)*
1.00
1.39 (1.11; 1.73)*
1.86 (1.48; 2.35)*
3.81 (2.04; 7.12)*
Energy drink consumption None
1 drink/day
2-3 drinks/day
>= 3 drinks/day
1.00
0.93 (0.72; 1.20)
1.47 (0.81; 2.65)
3.21 (1.62; 6.36)*
1.00
0.83 (0.63; 1.08)
1.10 (0.59; 2.05)
1.21 (0.55; 2.66)
Calcium supplements Yes vs. No 1.14 (0.89; 1.46) -
Vitamin D supplements Yes vs. No 1.02 (0.82; 1.26) -
Contraceptive pills Yes vs. No 1.24 (0.97; 1.60) -
Medication used for Pain, Yes vs. No
Nausea, Yes vs. No
Vomiting, Yes vs. No
Sleeping pills, Yes vs. No
1.57 (1.32; 1.88)*
1.89 (1.47; 2.44)*
1.90 (1.43; 2.53)*
3.18 (1.88; 5.40)*
1.34 (1.11; 1.62)*
1.38 (1.00; 1.91)
1.14 (0.80; 1.64)
2.15 (1.23; 3.76)*
*P-values < 0.05. 
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Table 3: Frequencies of premenstrual symptoms (not part of PMS definition) reported by the participants.
All participants N = 2115 N (%) Non-PMS N = 794 N (%) PMS N = 1321 N (%)
Mood swings 1361 (64.3) 302 (38.0) 1059 (80.2)
Tension in relationships 826 (39.1) 155 (19.5) 671 (50.8)
Disrupted relationship 404 (19.1) 63 (7.90) 341 (25.8)
Forgetfulness 404 (19.1) 68 (8.60) 336 (25.4)
Easily crying 976 (46.1) 196 (24.7) 780 (59.0)
Absence (work or university) 341 (16.1) 51 (6.40) 290 (22.0)
Appetite increase 1251 (59.1) 368 (46.3) 883 (66.8)
Craving salty foods 888 (42.0) 228 (28.7) 660 (50.0)
Craving sweets 1200 (56.7) 356 (44.8) 844 (63.9)
Weakness 712 (33.7) 152 (19.1) 560 (42.4)
Weight gain 614 (29.0) 85 (10.7) 529 (40.0)
Dizziness 340 (16.1) 38 (4.80) 302 (22.9)
Backache 1139 (53.9) 265 (33.4) 874 (66.2)
Menstrual cramps 1001 (47.3) 261 (32.9) 740 (56.0)
Heart palpitations 282 (13.3) 49 (6.20) 233 (17.6)
Constipation 340 (16.1) 56 (7.10) 284 (21.5)
Diarrhea 266 (12.6) 48 (6.00) 218 (16.5)
Hives, rashes 161 (7.60) 35 (4.40) 126 (9.50)
Acne 675 (31.9) 152 (19.1) 523 (39.6)
Oily skin 490 (23.2) 96 (12.1) 394 (29.8)
Insomnia 524 (24.8) 111 (14.0) 413 (31.3)
Table 4: Unadjusted and adjusted associations between sociodemographic, health behavior and health related factors and PMS 
affective and somatic domains.
PMS affective domain# PMS somatic domain##
Unadjusted OR 
(95% CI)
Adjusted OR 
(95% CI)
Unadjusted OR 
(95% CI)
Adjusted OR 
(95% CI)
Age, years [21-29] vs. [17-21] 0.99 (0.81; 1.23) - 1.20 (0.99; 1.46) -
Body mass index (BMI), 
kg/m²
< 18.5 
18.5 - 25
25 - 30 
>= 30 
1.00
1.13 (0.83; 1.55)
1.04 (0.71; 1.52)
1.64 (0.96; 2.80)
- 1.00
1.45 (1.11; 1.91)*
2.45 (1.71; 3.51)*
2.46 (1.52; 3.96)*
1.00
1.43 (1.08; 1.90)*
2.16 (1.49; 3.12)*
2.01 (1.22; 3.29)*
Smoking status Smokers vs. non-
smokers and ex-smokers
1.06 (0.83; 1.36) - 0.99 (0.79; 1.23) -
Age at menarche, years >= 12 vs. < 12 0.93 (0.74; 1.16) - 0.84 (0.69; 1.03) -
Family profile Dead (1 or both) vs. alive 1.14 (0.69; 1.87) - 3.29 (1.79; 6.06)* 2.61 (1.38; 4.94)*
Mother education University vs. high school 
or below
1.02 (0.82; 1.26) - 0.88 (0.73; 1.07) -
Mother occupation Employed vs. housewife 1.03 (0.82; 1.29) - 1.06 (0.87; 1.30) -
Mother income/month None
US$ < 2000
1.00
0.99 (0.78; 1.27)
- 1.00
1.12 (0.90; 1.40)
-
US$ >= 2000 1.17 (0.77; 1.79) 0.90 (0.63; 1.29)
Father education University vs. high school 
or below
1.04 (0.83; 1.30) - 0.83 (0.68; 1.01) -
Father occupation Employed vs. 
unemployed
0.80 (0.51; 1.26) 0.51 (0.33; 0.80)*
Father income/month None
US$ < 2000
1.00
0.76 (0.48; 1.20)
- 1.00
0.49 (0.31; 0.77)*
1.00
0.65 (0.40; 1.05)
US$ >= 2000 0.85 (0.54; 1.35) - 0.54 (0.34; 0.85)* 0.66 (0.41; 1.08)
Living conditions Dorms
With parents
Others
2.00
0.89 (0.69; 1.15)
0.80 (0.46; 1.37)
- 1.00
0.77 (0.61; 0.98)*
1.04 (0.62; 1.77)
1.00
0.82 (0.64; 1.05)
1.00 (0.58; 1.73)
University Private vs. public 1.01 (0.82; 1.25) - 1.19 (0.98; 1.44) -
Major Sciences & Medical 
Humanities & Business
Engineering
1.00
1.52 (1.20; 1.93)*
0.92 (0.70; 1.21)
-
1.47 (1.16; 1.88)*
0.90 (0.68; 1.19)
1.00
1.04 (0.84; 1.28)
0.87 (0.67; 1.13)
-
Exercise/week >= 3 times vs. < 3 times 0.83 (0.65; 1.06) - 0.97 (0.77; 1.22) -
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Caffeine consumption None
1 cup/day
2-3 cups/day
>= 3 cups/day
1.00
1.51 (1.18; 1.94)*
2.10 (1.61; 2.73)*
20.59 (5.03; 84.3)*
1.00
1.50 (1.16; 1.93)*
2.03 (1.55; 2.66)*
16.6 (3.89; 71.0)*
1.00
1.24 (0.99; 1.56)
1.58 (1.24; 2.00)*
3.35 (1.86; 6.02)*
1.00
1.33 (1.05; 1.68)*
1.46 (1.14; 1.86)*
2.70 (1.43; 5.08)*
Energy drink 
consumption
None
1 drink/day
2-3 drinks/day
>= 3 drinks/day
1.00
0.89 (0.66; 1.20)
1.21 (0.60; 2.42)
2.56 (1.10; 5.99)*
1.00
0.82 (0.60; 1.11)
0.93 (0.45; 1.91)
0.79 (0.30; 2.06)
1.00
0.87 (0.66; 1.13)
1.64 (0.84; 3.21)
2.18 (1.10; 4.33)*
1.00
0.78 (0.59; 1.03)
1.32 (0.66; 2.65)
0.95 (0.43; 2.09)
Calcium supplements Yes vs. No 1.03 (0.77; 1.37) - 0.91 (0.71; 1.18) -
Vitamin D supplements Yes vs. No 0.90 (0.70; 1.16) - 0.97 (0.77; 1.22) -
Contraceptive pills Yes vs. No 1.16 (0.86; 1.57) - 1.38 (1.05; 1.82)* 1.29 (0.97; 1.71)
Medication used for Pain, Yes vs. No
Nausea, Yes vs. No
Vomiting, Yes vs. No
Sleeping pills, Yes vs. No
1.96 (1.59; 2.42)*
1.69 (1.24; 2.31)*
1.75 (1.23; 2.50)*
2.95 (1.48; 5.89)*
1.70 (1.36; 2.13)*
1.22 (0.83; 1.80)
1.10 (0.71; 1.70)
1.95 (0.95; 4.01)
1.44 (1.19; 1.73)*
1.88 (1.42; 2.49)*
1.82 (1.33; 2.49)*
2.53 (1.45; 4.41)*
1.24 (1.01; 1.51)*
1.46 (1.03; 2.07)*
1.11 (0.75; 1.63)
1.75 (0.98; 3.15)
*P-values < 0.05. 
#PMS affective domain includes the following symptoms: Depression, anxiety, angry outbursts, irritability, confusion or the thought 
to commit suicide during the five days preceding menses in each of the three prior menstrual cycles; ##PMS somatic domain in-
cludes the following symptoms: Breast tenderness, swelling of extremities, abdominal bloating, fluid retention or headache during 
the five days preceding menses in each of the three prior menstrual cycles.
Table 5: Unadjusted and adjusted associations between symptoms that accompany PMS, presence of PMS, affective and so-
matic domains.
 PMS (N = 1321) PMS affective domain# (N = 1663) PMS somatic domain## (N = 1494)
Symptoms Unadjusted OR 
(95% CI)
Adjusted OR 
(95% CI)
Unadjusted OR 
(95% CI)
Adjusted OR 
(95% CI)
Unadjusted OR 
(95% CI)
Adjusted OR 
(95% CI)
Mood swings 6.59 (5.41; 8.02)* 3.77 (2.98; 4.76)* 16.5 (12.6; 21.6)* 9.65 (7.13; 13.0)* 3.85 (3.16; 4.69)* 1.93 (1.53; 2.45)*
Tense 
relationships
4.26 (3.46; 5.23)* 1.58 (1.22; 2.04)* 6.86 (5.05; 9.33)* 2.33 (1.60; 3.40)* 3.21 (2.59; 3.99)* 1.15 (0.88; 1.50)
Disrupted 
relationship
4.04 (3.04; 5.37)* 1.21 (0.84; 1.74) 4.62 (3.08; 6.92)* 1.28 (0.75; 2.17) 3.94 (2.85; 5.44)* 1.18 (0.80; 1.74)
Forgetfulness 3.64 (2.76; 4.81)* 1.60 (1.12; 2.27)* 9.59 (5.56; 16.5)* 4.85 (2.61; 9.03)* 2.74 (2.05; 3.66)* 1.15 (0.81; 1.65)
Easily crying 4.40 (3.62; 5.35)* 1.93 (1.52; 2.44)* 8.37 (6.25; 11.2)* 3.22 (2.29; 4.52)* 3.43 (2.79; 4.22)* 1.60 (1.25; 2.04)*
Absenteeism 4.10 (3.00; 5.60)* 1.17 (0.79; 1.74) 4.41 (2.85; 6.83)* 1.22 (0.70; 2.15) 4.10 (3.00; 5.60)* 1.21 (0.79; 1.84)
Appetite 
increase
2.33 (1.95; 2.80)* 1.23 (0.97; 1.56) 2.90 (2.34; 3.60)* 1.68 (1.25; 2.27)* 2.14 (1.77; 2.58)* 1.11 (0.88; 1.41)
Craving salty 
foods
2.48 (2.05; 2.99)* 1.37 (1.08; 1.74)* 2.77 (2.19; 3.51)* 1.35 (0.99; 1.85) 2.30 (1.88; 2.82)* 1.18 (0.92; 1.50)
Craving 
sweets
2.18 (1.82; 2.61)* 1.02 (0.80; 1.29) 2.23 (1.81; 2.76)* 0.90 (0.67; 1.21) 2.42 (2.00; 2.94)* 1.36 (1.08; 1.73)*
Weakness 3.11 (2.53; 3.83)* 1.29 (0.98; 1.69) 3.18 (2.43; 4.16)* 1.11 (0.77; 1.60) 3.36 (2.66; 4.25)* 1.44 (1.09; 1.91)*
Weight gain 5.57 (4.34; 7.16)* 3.08 (2.29; 4.14)* 3.93 (2.89; 5.33)* 1.54 (1.05; 2.28)* 7.28 (5.33; 9.95)* 3.83 (2.73; 5.38)*
Dizziness 5.90 (4.15; 8.37)* 2.81 (1.84; 4.29)* 5.15 (3.23; 8.19)* 1.99 (1.12; 3.53)* 5.16 (3.50; 7.60)* 2.42 (1.54; 3.78)*
Backache 3.90 (3.24; 4.70)* 1.83 (1.44; 2.32)* 4.03 (3.21; 5.07)* 1.63 (1.20; 2.22)* 3.67 (3.01; 4.48)* 1.69 (1.33; 2.15)*
Menstrual 
cramps
2.60 (2.17; 3.13)* 0.91 (0.71; 1.17) 2.72 (2.18; 3.41)* 0.93 (0.67; 1.28) 2.87 (2.35; 3.50)* 1.14 (0.89; 1.47)
Heart 
palpitations
3.26 (2.36; 4.49)* 1.58 (1.06; 2.37)* 3.82 (2.42; 6.04)* 1.46 (0.82; 2.58) 2.49 (1.78; 3.48)* 1.10 (0.73; 1.65)
Constipation 3.61 (2.67; 4.88)* 1.44 (0.99; 2.10) 2.50 (1.75; 3.58)* 0.73 (0.45; 1.20) 4.78 (3.28; 6.97)* 2.04 (1.33; 3.14)*
Diarrhea 3.07 (2.22; 4.26)* 1.67 (1.12; 2.48)* 2.90 (1.89; 4.43)* 1.58 (0.92; 2.74) 3.42 (2.33; 5.01)* 1.72 (1.12; 2.64)*
Hives, rashes 2.29 (1.56; 3.36)* 1.00 (0.61; 1.64) 2.13 (1.30; 3.48)* 0.89 (0.46; 1.71) 3.13 (1.94; 5.05)* 1.45 (0.83; 2.52)
Acne 2.77 (2.25; 3.41)* 1.49 (1.14; 1.95)* 2.33 (1.81; 3.01)* 1.14 (0.81; 1.61) 3.31 (2.61; 4.20)* 1.71 (1.29; 2.27)*
Oily skin 3.09 (2.42; 3.94)* 1.15 (0.83; 1.57) 3.05 (2.22; 4.19)* 1.14 (0.74; 1.76) 3.86 (2.89; 5.17)* 1.55 (1.10; 2.19)*
Insomnia 2.80 (2.22; 3.53)* 1.58 (1.18; 2.12)* 3.13 (2.92; 4.26)* 1.92 (1.29; 2.86)* 2.96 (2.28; 3.85)* 1.75 (1.28; 2.38)*
*P-values < 0.05. 
#PMS affective domain includes the following symptoms: Depression, anxiety, angry outbursts, irritability, confusion or the thought 
to commit suicide during the five days preceding menses in each of the three prior menstrual cycles; ##PMS somatic domain in-
cludes the following symptoms: Breast tenderness, swelling of extremities, abdominal bloating, fluid retention or headache during 
the five days preceding menses in each of the three prior menstrual cycles.
factors were associated with PMS affective domains: 
studying in the humanities or business faculties [1.47 
as premenstrual symptoms not part of the PMS defini-
tion, regardless of PMS status (Table 3). The following 
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1000 women according to International Classification 
of Disease (ICD-10), ACOG, and DSM-IV criteria, respec-
tively. Over 40% of the participants with PMS reported 
having severe symptoms. A previous study conducted 
among medical students found that severe symptoms 
were reported by 22.4% of the participants (with a PMS 
prevalence of 35.6%) [19] However, the diverse study 
groups and the different methods used in estimating 
the symptoms severity prevent the between-studies 
comparison. Nevertheless, we think that the high rate 
we obtained is mainly due to the students’ good percep-
tions of their symptoms.
The most frequent affective symptoms were angry 
outbursts (77.4%) and irritability (66.8%) and the most 
common somatic symptoms were abdominal bloating 
(70.8%) and breast tenderness (50.1%). The most com-
mon symptoms reported here are consistent for diverse 
study groups such as medical students [10], medical stu-
dents and medical health caregivers [12], or high school 
adolescents [16], which confirm our results. Other stud-
ies have reported that the most common symptoms 
among 15 to 19-years-old adolescents were difficulty 
concentrating, fatigue or lack of energy, and food crav-
ings [7], poor individual work performance [16], and 
backaches [17]. Moreover, the present study found that 
symptoms that mostly accompany PMS affective domain 
were mood swings, forgetfulness, and easily crying. In 
addition, weight gain, dizziness and constipation were 
found to be mostly related to PMS somatic domain. To 
our knowledge, affective and somatic domains were not 
previously explored, thereby preventing comparison.
PMS etiology is multifactorial [17,22,23]. PMS was 
positively associated with increasing BMI in this study. 
A cross-sectional study conducted among 874 women 
aged 18 to 44 reported that obese women had almost 
a three-fold increased risk for PMS compare to under-
weight women [24]. Furthermore, another prospective 
study conducted among women free from PMS at base-
line (n = 1057) and aged 27 to 44-years-old found that 
obese women at baseline had significantly higher risks 
of developing PMS over 10 years of follow-up [25]. It 
is thought that obesity modifies neurotransmitter func-
tion through its effect on estrogen and progesterone. 
Estrogen enhances serotonin action by increasing its 
synthesis, transport, reuptake and receptor expression, 
and postsynaptic responsiveness. Therefore, lower es-
tradiol levels associated with adiposity may lead to im-
paired serotonin function and contribute to the occur-
rence of PMS [25].
A dose-response relationship between PMS and caf-
feine consumption was found. Our results are in concor-
dance with previous research reporting that PMS is sig-
nificantly high in students who consume 2 cups of coffee 
or above per day [17,26]. The reason behind this finding 
is that caffeine is a stimulant and it increases stress and 
emotional lability [27]. Moreover, this study found that 
(1.16; 1.88)], caffeine consumption [1.50 (1.16; 1.93), 
2.03 (1.55; 2.66) and 16.6 (3.89; 71.0) for 1 cup, 2-3 cups 
and >= 3 cups per day, respectively], and pain medica-
tion use [1.70 (1.36; 2.13)]. Factors associated with PMS 
somatic domain were BMI [1.43 (1.08; 1.90), 2.16 (1.49; 
3.12) and 2.01 (1.22; 3.29) for normal, overweight and 
obese participants], family profile [2.61 (1.38; 4.94) for 
having one or both parents dead], caffeine consumption 
[1.33 (1.05; 1.68), 1.46 (1.14; 1.86) and 2.70 (1.43; 5.08) 
for 1 cup, 2-3 cups and >= 3 cups per day, respectively], 
and medication use for pain [1.24 (1.01; 1.51)] and for 
nausea [1.46 (1.03; 2.07)] (Table 4). Mood swings [(a) 
OR (95% CI) = 3.77 (2.98; 4.76)], weight gain, [3.08 (2.29; 
4.14)], and dizziness [2.81 (1.84; 4.29)] showed the 
strongest associations with PMS; while mood swings 
[9.65 (7.13; 13.0)], forgetfulness [4.85 (2.61; 9.03)], and 
crying easily [3.22 (2.29; 4.52)] showed the strongest 
associations with PMS affective domains. On the oth-
er hand, PMS somatic domains were mostly associat-
ed with weight gain [3.83 (2.73; 5.38)], dizziness [2.42 
(1.54; 3.78)] and constipation [2.04 (1.33; 3.14)], as out-
lined in Table 5.
Discussion
This study identified the proportion, severity and 
PMS associated factors among female university stu-
dents in Lebanon and explored both the affective and 
somatic PMS domains, as well as the symptoms that ac-
company PMS. The findings showed that PMS is present 
in 62.5% of participants. Moreover, the factors positive-
ly related to PMS included obesity, having unemployed 
fathers, caffeine consumption, and medication use for 
pain and sleeping pills. The factors associated with PMS 
affective domains were majoring in humanities or busi-
ness, caffeine consumption, and medication use for 
pain, while those associated with PMS somatic domain 
were obesity, having one or both parents dead, caffeine 
consumption, and medication use for pain and nausea.
A high proportion of participants reported having 
PMS (62.5%). Previously, a brief communication pub-
lished in Lebanon showed a prevalence of 7.1% among 
medical students and medical health caregivers [12]. 
However, differences in sample size and study popula-
tion prevent any direct between-study comparison. The 
variation in PMS prevalence within and between coun-
tries might be due to diagnostic criteria and assessment 
tools. Additional factors include cultural differences, 
types of studied populations, data collection methods 
used, and participants’ honesty in reporting their symp-
toms [1,17,18]. Previous research have reported a wide 
range of PMS prevalence in various countries from 12% 
in France to 98% in Iran [6]. In the surrounding coun-
tries, PMS prevalence was found to be 35.6% in Sau-
di Arabia among medical students [19], 65% in Egypt 
among adolescents [20], and 72.1% in Turkey among 
Medical students [17]. Choi, et al. [21] indicated a PMS 
prevalence of 98.6%, 32.1% and 2.8% in a sample of 
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